Zydus Lifesciences Ltd gets 4 observations from USFDA for Moraiya facility

The USFDA conducted an inspection of Zydus Lifesciences Ltd's Moraiya manufacturing facility located at Ahmedabad from 26th July to 5th August, 2022. The inspection concluded with four Form 483 observations. None of the observations were related to data integrity. The Company will address the observations within the stipulated timeline.

Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 364.55 as compared to the previous close of Rs. 346.35. The total number of shares traded during the day was 150269 in over 3267 trades.

The stock hit an intraday high of Rs. 365.50 and intraday low of 346.10. The net turnover during the day was Rs. 53643799.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Moraiya Facility USFDA Inspection 4Observations Form483